Stem cell therapies are particularly important for addressing the challenges arise from the body's restricted capacity to repair and rejuvenate injured tissues and metabolic processes after experiencing acute or chronic damage. The origin of stem cell therapy can be traced back to 1991 when Caplan introduced the concept. Caplan theorized that the manipulation of stem cells in a controlled laboratory setting could lead to the significant development of specific tissues. Among the various types of stem cells, Mesenchymal stem cells (MSC) are particularly favored for therapeutic applications because of their straightforward isolation and cultivation processes, as well as the absence of ethical concerns surrounding their use among the various types of stem cells. Their ability to modulate the immune system is increasingly acknowledged in veterinary medicine. The advancements in this specific field have primarily been propelled by the inadequacies of current treatment options for different medical ailments in a range of animal species.